PT99245A - Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem - Google Patents

Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem

Info

Publication number
PT99245A
PT99245A PT99245A PT9924591A PT99245A PT 99245 A PT99245 A PT 99245A PT 99245 A PT99245 A PT 99245A PT 9924591 A PT9924591 A PT 9924591A PT 99245 A PT99245 A PT 99245A
Authority
PT
Portugal
Prior art keywords
pellets
substance
pct
dosage
pharmaceutical composition
Prior art date
Application number
PT99245A
Other languages
English (en)
Other versions
PT99245B (pt
Inventor
Arne Kristensen
Per Holm
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of PT99245A publication Critical patent/PT99245A/pt
Publication of PT99245B publication Critical patent/PT99245B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99245A 1990-10-16 1991-10-16 Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem PT99245B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003296A SE9003296L (sv) 1990-10-16 1990-10-16 Foerfarande foer att formulera laekemedel

Publications (2)

Publication Number Publication Date
PT99245A true PT99245A (pt) 1992-09-30
PT99245B PT99245B (pt) 1999-04-30

Family

ID=20380654

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99245A PT99245B (pt) 1990-10-16 1991-10-16 Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem

Country Status (14)

Country Link
US (1) US5476667A (pt)
EP (1) EP0553169B1 (pt)
JP (1) JP3459011B2 (pt)
AT (1) ATE131727T1 (pt)
AU (1) AU650683B2 (pt)
CA (1) CA2094030C (pt)
DE (1) DE69115711T2 (pt)
DK (1) DK0553169T3 (pt)
ES (1) ES2081498T3 (pt)
GR (1) GR3019360T3 (pt)
IE (1) IE74194B1 (pt)
PT (1) PT99245B (pt)
SE (1) SE9003296L (pt)
WO (1) WO1992006679A1 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
GB2284760B (en) * 1993-11-23 1998-06-24 Euro Celtique Sa A method of preparing pharmaceutical compositions by melt pelletisation
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
IL109944A (en) † 1993-07-01 1998-12-06 Euro Celtique Sa Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
WO1995009044A1 (en) * 1993-09-29 1995-04-06 E.I. Du Pont De Nemours And Company Melt granulation with dielectric heating
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
ATE212224T1 (de) * 1993-11-23 2002-02-15 Euro Celtique Sa Verfahren zur herstellung einer arzneizusammensetzung mit verzögerter wirkstoffabgabe
EP0672416A1 (en) * 1994-03-14 1995-09-20 Euro-Celtique S.A. Pharmaceutical composition comprising diamorphine
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9422154D0 (en) † 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
SE9700934D0 (sv) 1997-03-14 1997-03-14 Astra Ab New formulation
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
PT1146862E (pt) 1999-01-29 2003-09-30 Disphar Int Bv Composicoes farmaceuticas
US6248718B1 (en) 1999-08-18 2001-06-19 Atlantic Biomed Corporation Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
ES2374717T3 (es) 1999-10-29 2012-02-21 Euro-Celtique S.A. Formulaciones de hidrocodona de liberación controlada.
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
JP2004512354A (ja) 2000-10-30 2004-04-22 ユーロ−セルティーク，エス．エイ． ヒドロコドン放出制御製剤
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
ATE554752T1 (de) 2004-02-06 2012-05-15 Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
US8921344B2 (en) 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP1972335A1 (en) * 2007-03-23 2008-09-24 Krka Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
FR2918277B1 (fr) * 2007-07-06 2012-10-05 Coretecholding Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2704209C (en) 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
US8871263B2 (en) 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
FR3014317B1 (fr) 2013-12-11 2016-04-22 Patrice Binay Nouveau procede de fabrication de formulations pharmaceutiques transmuqueuses et formations ainsi obtenues
WO2015105992A1 (en) 2014-01-10 2015-07-16 Mcneil-Ppc, Inc. Process for making tablet using radiofrequency and lossy coated particles
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
US4129666A (en) * 1977-04-29 1978-12-12 Walter Wizerkaniuk Method of providing pellets with a water insoluble coating using a melt
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten

Also Published As

Publication number Publication date
IE913627A1 (en) 1992-04-22
JP3459011B2 (ja) 2003-10-20
SE9003296D0 (sv) 1990-10-16
ATE131727T1 (de) 1996-01-15
DE69115711T2 (de) 1996-05-30
GR3019360T3 (en) 1996-06-30
DK0553169T3 (da) 1996-05-13
AU8745991A (en) 1992-05-20
AU650683B2 (en) 1994-06-30
CA2094030A1 (en) 1992-04-17
IE74194B1 (en) 1997-07-16
EP0553169B1 (en) 1995-12-20
PT99245B (pt) 1999-04-30
CA2094030C (en) 2003-06-17
DE69115711D1 (de) 1996-02-01
US5476667A (en) 1995-12-19
ES2081498T3 (es) 1996-03-16
JPH06502151A (ja) 1994-03-10
SE9003296L (sv) 1992-04-17
WO1992006679A1 (en) 1992-04-30
EP0553169A1 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
PT99245A (pt) Processo para a preparaccao de uma substancia sob a forma granulada contendo nomeadamente um sal de acido azobissalicilico e de uma composicao farmaceutica que a contem
SE9200858L (sv) Metod för framställning av pellets med fördröjd frisättning
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
ES470335A1 (es) Un metodo para preparar una composicion que contiene carbonoen forma purificada y pulverizada,asi como agua y un agente dispersante
ZA200005915B (en) Pharmaceutical compositions capable of being gelled.
BR9703417B1 (pt) processo para a fabricaÇço de um suplemento de raÇço animal À base de caldo de fermentaÇço.
ES2041641T3 (es) Granulos que contienen vitaminas y procedimientos para su produccion.
ATE20565T1 (de) Kaltloesliche tee-extraktpulver.
BR9912846B1 (pt) processo para fabricar um tablete de liberação controlada.
KR960703566A (ko) 비등성 입자와 이의 제조공정(effervescent granulated material and method for its preparation)
MX9206420A (es) Procedimiento para aglomerar material en particulas y productos hechos a partir de dicho procedimiento.
HU905275D0 (en) Process for producing new omega-phenyl-amino-alkanic acid derivatives and pharmaceutical preparatives containing these compounds as active substance
DK166946B1 (da) Fremgangsmaade til ved injektionsstoebning at fremstille boluspraeparater med forsinket frigivelse
MX9305539A (es) Procedimiento para la fabricacion de pellets a partir de un derivado de efedrina.
JP2007014954A (ja) 高脱水ライムケーキの造粒方法
WO1997010810A3 (en) Pharmaceutical granules
AU551212B2 (en) Sustained release lithium carbonate tablets and method for their manufacture
CN101427733A (zh) 用于动物饲料的包衣维生素k制剂的制备方法
BR8306195A (pt) Processo para a producao de granulos de magnesio revestidos com sais
IE38550B1 (en) Method of making tablets
JPS55132627A (en) Granulating method
MEP48008A (en) Controlled release oxycodone compositions
NO992942L (no) Ureaprodukt med kontrollert l°selighet, fremgangsmÕte for dets fremstilling samt anvendelse av produktet som f¶rsupplement
TH9681EX (th) วิธีการทำ l-ไลซีนเม็ดละเอียด

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920525

FG3A Patent granted, date of granting

Effective date: 19990107

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080707